Results 151 to 160 of about 8,893,093 (256)

A Novel Air‐Liquid Interface Exposure System for Continuous Gas Exposure of Airway Epithelial Cells: Exposure of NO2 With Viral Co‐Challenge

Journal of Applied Toxicology, Volume 46, Issue 9, Page 3113-3125, September 2026.
ABSTRACT Most in vitro toxicological research investigating the effects of inhaled compounds employ short‐term exposures of a couple of hours, or repeated, intermittent exposures for a limited number of days with exposure free periods, whereas in reality, we are continuously exposed, albeit to variable concentrations.
Marcia M. Oldenburger, Evert Duistermaat, Pieter S. Hiemstra, Flemming R. Cassee, Yvonne C. M. Staal   +4 more
wiley   +1 more source

The development of recombinant Adenoviral vaccines to target pneumovirus infection [PDF]

Respiratory Syncytial Virus (RSV) is a member of the pneumovirus genus (family Paramyxoviridae, subfamily Pneumovirinae). RSV is an important respiratory virus of both infants and the elderly, representing an underappreciated burden on health care ...
Terry, Helen Elizabeth
core  

Pan‐gammaherpesvirus control via a broadly neutralising gB antibody

Clinical and Translational Medicine, Volume 16, Issue 9, September 2026.
Zi‐Ying Jiang, Peng‐Lin Li, Chu Xie, Cong Sun   +3 more
wiley   +1 more source

Eligibility‐Identification Difficulty and Self‐Reported Preventive Care Implementation Among Japanese Primary Care Physicians

Journal of General and Family Medicine, Volume 27, Issue 5, September 2026.
ABSTRACT Background Primary care is an important setting for prevention, but implementation gaps may arise before clinicians can identify patients eligible for preventive services. We described self‐reported preventive care implementation among Japanese primary care physicians and examined whether lower implementation co‐occurred with eligibility ...
Hironori Yamada, Kei Miyazaki, Makito Yaegashi, Kuniko Nakayama, Rei Suganaga, Nobuaki Kusaka, Wataru Hirohashi, Tomio Suzuki   +7 more
wiley   +1 more source

Respiratory syncytial virus, human metapneumovirus, and influenza virus infection in Bangkok, 2016-2017. [PDF]

PeerJ, 2019
Thongpan I, Suntronwong N, Vichaiwattana P, Wanlapakorn N, Vongpunsawad S, Poovorawan Y.   +5 more
europepmc   +1 more source

Inducing Antigen‐Specific and Functional Immune Responses in Mice Toward Bovine Herpesvirus 1 and Bovine Respiratory Syncytial Virus by Chimeric Peptides Delivered by Bovine Herpesvirus 4‐Based Vector

Immunology, Volume 179, Issue 1, Page 54-71, September 2026.
Bovine Alphaherpesvirus 1 (BoHV‐1) and Bovine respiratory syncytial virus (BRSV) are major drivers of respiratory disease in cattle. (A) To target both pathogens, two chimeric antigens—membrane‐linked and secreted—combining BoHV‐1 glycoprotein D and BRSV fusion glycoprotein were designed and expressed using recombinant BoHV‐4‐based vectors.
Antonino Di Lorenzo, Sergio Minesso, Chiara Cossu, Valentina Franceschi, Elisabetta Bolli, Vittorio Madia, Laura Conti, Gaetano Donofrio   +7 more
wiley   +1 more source

Respiratory syncytial virus: current and emerging treatment options

, 2014
Tiffany L Turner,1 Benjamin T Kopp,1 Grace Paul,1 Lindsay C Landgrave,2 Don Hayes Jr,1 Rohan Thompson11Department of Pediatrics, Ohio State University College of Medicine, 2Clinical Pharmacy, Nationwide Children's Hospital, Columbus, OH, USAAbstract:
Thompson R, Turner TL, Kopp BT, Landgrave LC, Paul G, Hayes D Jr   +5 more
core  

Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU)

, 2020
Respiratory syncytial virus (RSV) is the leading viral pathogen associated with acute lower respiratory tract infection and hospitalization in children < 5 years of age worldwide.
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators
core  

Respiratory Syncytial Virus Symptomatic Fraction, Shedding and Detection in Children Aged 6–23 Months in South Africa in 2022

Influenza and Other Respiratory Viruses, Volume 20, Issue 9, September 2026.
ABSTRACT Background Accurate detection of RSV infections is important to understand epidemiology. We estimated symptomatic fraction and shedding duration of reverse‐transcription polymerase chain reaction (RT‐PCR)‐confirmed cases and compared RSV detection through molecular and serologic techniques. Methods We enrolled healthy children aged 6–23 months
Cheryl Cohen, Mignon du Plessis, Neil Martinson, Jocelyn Moyes, Sibongile Walaza, Nicole Wolter, Mvuyo Makhasi, Fahima Moosa, Myrna Charles, Aaron M. Samuels, Stefano Tempia, Tumelo Moloantoa, Bekiwe Ncwana, Louisa Phalatse, Lorens Maake, Amelia Buys, Caitlyn Labuschagne, Cayla Reddy, Wilhelmina Ubbink, Nokuthula Linda, Eva Leidman, Eduardo Azziz Baumgartner, Anne von Gottberg, Jackie Kleynhans   +23 more
wiley   +1 more source

Assessing the Utility of Over‐The‐Counter Medication to Track Influenza Season Timing in a South African Population

Influenza and Other Respiratory Viruses, Volume 20, Issue 9, September 2026.
ABSTRACT Background Laboratory‐based influenza surveillance in low‐ and middle‐income countries may have limited timeliness and geographic coverage. We evaluated whether over‐the‐counter (OTC) respiratory medication sales track seasonal influenza activity and provide early warning of influenza onset in South Africa.
Malebo Sephule Makunyane, Neville Sweijd, Jhandre Bredenkamp, Sibongile Walaza, Cheryl Cohen, Jonny Peter   +5 more
wiley   +1 more source